Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025)

Pulse Biosciences (PLSE) posted quarterly Change in Receivables of $259000.0 for Q4 2025, up 5280.0% quarter-over-quarter from -$5000.0 in Q4 2022.

Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025) Analysis & Trends

Pulse Biosciences' Change in Receivables history runs 3 years deep, the most recent figure standing at $259000.0 for Q4 2025.

In Q4 2025, Change in Receivables changed N/A year-over-year to $259000.0; the TTM figure through Dec 2025 stood at $259000.0 (changed N/A YoY), while the FY2025 annual figure was $274000.0, changed N/A from the prior year.
Change in Receivables for Q4 2025 stood at $259000.0, up from -$5000.0 in the prior quarter.
The five-year high for Change in Receivables was $259000.0 in Q4 2025, with the low at -$40000.0 in Q1 2022.
The 3-year median for Change in Receivables is -$8000.0 (2021), against an average of $31166.7.
Peak annual rise in Change in Receivables reached 54.55% in 2022, while the deepest fall reached 54.55% in 2022.
Pulse Biosciences' Change in Receivables stood at -$11000.0 in 2021, then surged by 54.55% to -$5000.0 in 2022, then surged by 5280.0% to $259000.0 in 2025.
Business Quant data shows PLSE's Change in Receivables at $259000.0 in Q4 2025, -$5000.0 in Q4 2022, and -$3000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	74.90 Mn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	-
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	-
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	37.21 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	2.00 Mn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	-
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	252.00 Mn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	-
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	156.00 Mn
10	Pulse Biosciences	3.50 Bn	3.50 Bn	161,000.00	-

Download Data